Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,460 | -8,462 | -4,446 | -10,731 | -6,894 |
| Accounts receivable | 682 | 672 | -112 | -1,319 | 283 |
| Accounts payable and accrued liabilities | -1,382 | -1,054 | -1,299 | 381 | -426 |
| Other Working Capital | -80 | 691 | -1,433 | -425 | 491 |
| Other Operating Activity | 1,127 | 775 | 1,791 | 1,184 | 338 |
| Operating Cash Flow | $-10,114 | $-7,378 | $-5,500 | $-10,910 | $-6,207 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,865 | 1 | 1 | 14,991 | 95 |
| Financing Cash Flow | $9,865 | $1 | $1 | $14,991 | $95 |
| Beginning Cash Position | 19,192 | 19,192 | 19,192 | 15,112 | 15,112 |
| End Cash Position | 18,943 | 11,815 | 13,693 | 19,192 | 9,000 |
| Net Cash Flow | $-250 | $-7,378 | $-5,499 | $4,081 | $-6,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,114 | -7,378 | -5,500 | -10,910 | -6,207 |
| Free Cash Flow | -10,114 | -7,378 | -5,500 | -10,910 | -6,207 |